22 patients with granulosa cell tl~nors were treated at the Gynaecological Department of the University of Cologne. They were admitted to the clinic because of irregular genital bleeding or pain. The existence of a granulosa cell t~ror was preoperatively considered only in a few cases, however the high degree of proliferation of the cervical smears from 11 out of 14 postmenopausal patients indicated the presence of an estrogen producing tt~nor. Hysterectomy and bilateral salpingo-oophorectomy were performed in most cases. 9 patients got additional irradation, 4 patients additional chemotherapy. In 3 young women only the involved adnexa was exstirpated to prevent infertility. Because premature ovarian failure is a significant adverse effect of chemotherapy it is important to explore its mechanism. The experiments reported here were designed to characterise the effect of cy on the non-human primate ovary at different phases of the ovarian cycle. Normal cycling cynomolgus monkeys were treated with cy iv at a dose of Ig/m ", equivalent to the dose used in humans, either prior to or following the LH surge. All monkeys were bled daily to determine LH, FSH, oestradiol and progesterone by RIA. Thus, a total of 16 treatment cycles was studied in 11 monkeys. Control data were obtained from untreated monkeys. Monkeys treated after the LH surge had normal !utea! phases and the follicu!ar phase of the subsequent cycle uas a!so norma~. ~reatme~t I day prior to the LH surge decreased both LH and progesterone secretion, the subsequent cycle ~as not disturbed. Treatment 2 to @ clays before the gonadotrophin surge produced a rapid and complete inhibition of oestradiol secretion, which lasted for more than 20 days; in the luteal phase of those monkeys, progesterone production was abolished. These data demonstrate that ovarian sensitivity to cy varies with the cycle. (5,5). We found s good correlation between tumor mass and sc in 87%(88/99) of pts with large tumor mass (CA 125 > i00 U/ml). Sc > i00 U/ml were found in 4/14 cases with small tumor mass. Progression was indicated by rising Ca 125 sc in 82% (42/ 5]), 28% of these preceeded the clinical diagnosis 2 -]2 months. A few cases with single raised sc of CA ]9-9 (5/183) and CEA (2/179) or CA ]5-3 (1/]07) were found. In 22 pts we found normal sc of CA 125. 14 were also negative for CA ]9-9, CA ]5-3 and CEA. Immunhistochemistry stained positive in tumor tissue in 83%(33/40) for CA 125, 45%(18/40) for CA 19-9 and 55%(22/ 40) for CEA. Only a certain portion of each tumor stained positively, in maximum 70% of tumor cells. High se correlated well with a high percentage of positively stained tumor cells. In 9 DiS serum samples and sscites were examined simultaneously. The mean value of CA 125 in ascites was markedly higher than in serum. Serum: 736 O/ml, ascites 1.229 U/ml. In monitoring advanced ovarian carcinoma CA 125 is superior to CEA, CA 19-9 and CA 15-3. There is still some controversy whether preservation of ovarian function in young patients with Hodgkin's disease undergoing irradiation can best be achieved by oophoropexy or ovarian transposition (Gynecologic Oncology -Controversies in Cancer Treas Ed. S.C. Ballon, Hall, Boston 1981). T:hls Question cannot be answered from the literature because most of the patients in the past only had irradiation and no chemotherapy. There is strong evidence that the combination of both is likely to result in ovarian failure, depending on age and drug combinations ( S.J. Horning et el., New Engl. J. Med. 304,1377 Med. 304, ,1981 . Having transposed ovaries in patients with pelvic tumors sucessfully, we started transposition in patients with Hodgkin's disease in combination with a modified radiation protocol. Conventional radiation will result in a calculated dose by skatter and penetration which is not tolerable in pretreat~d patients (approx. 4, 8 Gy 
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